MMP2 and ischemia: They stated that the post-reperfusion use of candesartan promotes increasing in matrix metalloproteinase-2 (MMP-2) activity and vascular endothelial growth factor (VEGF) expression in the myocardium, inducing the establishment of the angiogenic state induced by ischemia earlier than usual and therefore enhancing vascular protection.